Fortress Biotech
FBIO
#9362
Rank
โ‚ฌ78.01 M
Marketcap
2,51ย โ‚ฌ
Share price
-2.01%
Change (1 day)
57.88%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2025 (TTM): -โ‚ฌ50.14 Million

According to Fortress Biotech 's latest financial reports the company's current earnings are โ‚ฌ62.3 Million. In 2024 the company made an earning of -โ‚ฌ0.11 Billion, an increase over its 2023 earnings that were of -โ‚ฌ0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ50.14 Million-51.65%
2024 -โ‚ฌ0.11 Billion-21.6%
2023 -โ‚ฌ0.14 Billion-28.03%
2022 -โ‚ฌ0.19 Billion29.88%
2021 -โ‚ฌ0.15 Billion59.8%
2020 -โ‚ฌ88.54 Million1.17%
2019 -โ‚ฌ87.51 Million-19.84%
2018 -โ‚ฌ0.11 Billion28.99%
2017 -โ‚ฌ84.64 Million37.92%
2016 -โ‚ฌ61.37 Million32.31%
2015 -โ‚ฌ46.39 Million164.31%
2014 -โ‚ฌ17.55 Million-45.14%
2013 -โ‚ฌ31.99 Million37.55%
2012 -โ‚ฌ23.26 Million-22.91%
2011 -โ‚ฌ30.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Veracyte
VCYT
โ‚ฌ21.3 M-146.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ0.11 Billion 120.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-โ‚ฌ29.29 Million-36.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-โ‚ฌ29.18 Million-36.62%๐Ÿ‡บ๐Ÿ‡ธ USA